ELANCO UK AH LIMITED
Get an alert when ELANCO UK AH LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-06-05 (in 1mo)
Last made up 2025-05-22
Watchouts
None on the register
Accounts
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst & Young
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have assessed the ability of Elanco Animal Health Incorporated to provide the level of support that might be required and see no reason to believe that a material uncertainty exists that may cast significant doubt about the ability of Elanco UK AH Limited to continue as a going concern. On the basis of their assessment of the company's financial position, the Company's Directors have a reasonable expectation that the company will be able to continue in operational existence for the foreseeable future.”
Group structure
- ELANCO UK AH LIMITED · parent
- Dista Products Limited 100%
- Elanco Europe Limited 100%
- Vericore Limited 100%
- Elanco Animal Health UK Limited 100%
- Elanco Animal Vaccines Limited 100%
Significant events
- “In July 2024, Elancó globally completed the sale of its Aqua portfolio to Merck for $1.3bn, the proceeds of which contributed to debt paydown. For Elanco UK, Aqua was a relatively small business unit and has resulted in a reduction in annualised revenues of approximately £6.5m.”
- “In November 2024, the Company acquired a manufacturing facility in Speke, Liverpool which was owned and operated by a third party contract manufacturer until its administration in the 2nd half of 2024... result[ing] in our decision to acquire this manufacturing facility, safeguarding product supply and the employment of approximately 260 people...”
- “Under the UK Emissions Trading Scheme Order, the Company's Speke facility... had a failure to acquire and surrender credits... resulting in an outstanding liability to the Environment Agency (EA)... The legal basis for such a transfer is highly uncertain. The Company is cooperating with the EA... to demonstrate that it should not be held liable for costs incurred before the acquisition date.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 4 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| DAVIS, Nicholas | Director | 2025-04-01 | Jun 1975 | British |
| FROST, Matthew Jonathan | Director | 2021-07-01 | Jul 1972 | British |
| LEWIS, Christopher | Director | 2018-06-20 | Aug 1978 | British |
Show 4 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| AMBANI, Nilesh (Neel) Sukumar | Director | 2018-05-23 | 2018-12-07 |
| HUNT, Kristina Mary | Director | 2018-12-07 | 2026-01-23 |
| TROUTT, Peter | Director | 2018-06-20 | 2021-12-03 |
| VANHERSECKE, Francois Jean-Noel Emile | Director | 2019-09-05 | 2021-06-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Elanco Europe Gmbh | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors, significant-influence-or-control-as-firm | 2019-03-11 | Ceased 2019-03-11 |
| Elanco Animal Health Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2019-03-11 | Active |
| Eli Lilly And Company Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2018-05-23 | Ceased 2019-03-11 |
Filing timeline
Last 20 of 43 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-01-29 | TM01 | officers | Termination director company with name termination date | |
| 2025-11-07 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-08-21 | AA | accounts | Accounts with accounts type full | |
| 2025-06-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-05-22 | AP01 | officers | Appoint person director company with name date | |
| 2024-09-18 | MR05 | mortgage | Mortgage charge part release with charge number | |
| 2024-09-10 | AA | accounts | Accounts with accounts type full | |
| 2024-07-23 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-06-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-09 | AA | accounts | Accounts with accounts type full | |
| 2023-09-20 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2023-09-20 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2023-06-01 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-10-07 | AA | accounts | Accounts with accounts type full | |
| 2022-07-06 | RESOLUTIONS | resolution | Resolution | |
| 2022-07-06 | MA | incorporation | Memorandum articles | |
| 2022-06-16 | CH01 | officers | Change person director company with change date | |
| 2022-05-26 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-01-05 | AA | accounts | Accounts with accounts type full | |
| 2021-12-03 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
Latest filed period vs the prior one